Patient light chain amyloidogenicity
downstream-application
Patient light chain amyloidogenicity: downstream-application. Sequences of nine multiple myeloma and one AL amyloidosis light chains were solved by de novo mass spectrometry sequencing and used to show all have comparable…
Sequences of nine multiple myeloma and one AL amyloidosis light chains were solved by de novo mass spectrometry sequencing and used to show all have comparable amyloidogenic potential.
| Kind | downstream-application |
| Deep learning | no |
| Acquisition | DDA |
| Application area | Antibodyomics |
Paper describing it
- Universal amyloidogenicity of patient-derived immunoglobulin light chains (2021, bioRxiv, preprint)